|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-11-24
|
|
pubmed:abstractText |
To examine the utility and prognostic significance of enzymatic serum acid phosphatase (total acid phosphatase, TAP, and prostatic fraction of acid phosphatase, PFAP) and alkaline phosphatase (ALP) for staging, grading and outcome of patients who underwent radical retropubic prostatectomy (RRP) after the introduction of prostate-specific antigen (PSA) testing.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1464-4096
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
924-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14632848-Acid Phosphatase,
pubmed-meshheading:14632848-Aged,
pubmed-meshheading:14632848-Alkaline Phosphatase,
pubmed-meshheading:14632848-Biopsy,
pubmed-meshheading:14632848-Disease-Free Survival,
pubmed-meshheading:14632848-Humans,
pubmed-meshheading:14632848-Male,
pubmed-meshheading:14632848-Middle Aged,
pubmed-meshheading:14632848-Neoplasm Recurrence, Local,
pubmed-meshheading:14632848-Neoplasm Staging,
pubmed-meshheading:14632848-Postoperative Care,
pubmed-meshheading:14632848-Prostate-Specific Antigen,
pubmed-meshheading:14632848-Prostatectomy,
pubmed-meshheading:14632848-Prostatic Neoplasms,
pubmed-meshheading:14632848-Retrospective Studies
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Preoperative serum acid phosphatase and alkaline phosphatase are not predictors of pathological stage and prostate-specific antigen failure after radical prostatectomy.
|
|
pubmed:affiliation |
Division of Urologic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
